Synagis100mg (Palivizumab Vials) 100mg x 1.0mL

Synagis 100mg (Palivizumab) is an injectable vial used to help prevent serious lung infections caused by RSV in high-risk infants. Store between 2-8°C to maintain potency. This monoclonal antibody targets respiratory syncytial virus in vulnerable patients.

Strength

100mg x 1.0mL

Pack Size

Storage

2-8°

Manufacturer / TM Owner

AstraZeneca K.K.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Synagis 100mg is primarily used to reduce the risk of severe respiratory syncytial virus (RSV) infections in babies born prematurely or with certain heart or lung conditions. It may also be prescribed for children with weakened immune systems who face higher RSV complications. Parents often ask what Synagis 100mg is used for, and this vial helps protect during peak RSV season.

Side Effects

Synagis 100mg works by providing antibodies that help the immune system fight RSV before it causes serious illness. Many patients experience no noticeable effects, while some may notice mild redness or swelling at the injection site. The medication is designed to support the body’s natural defenses during high-risk periods.

Precautions & Warnings

Keep Synagis 100mg refrigerated between 2-8°C and protect from light. Do not freeze. Before use, inspect the vial for particles or discoloration; discard if either is present. Always follow healthcare provider instructions for administration and storage to ensure effectiveness.

Avoid Interactions

Synagis 100mg has a low risk of interactions with other medications due to its targeted antibody mechanism. However, patients receiving other injectable therapies should inform their healthcare provider. No specific drug interactions have been widely documented, but always disclose all medications to your doctor.

Frequently Asked Questions

Synagis 100mg is used to help prevent serious lung infections caused by respiratory syncytial virus (RSV) in high-risk infants and young children.

Synagis 100mg is given as an injection, typically once a month during RSV season, as directed by a healthcare provider.

No, Synagis 100mg must be refrigerated between 2-8°C and should not be frozen or exposed to light.

Synagis 100mg is prescribed for high-risk infants and children, such as those born prematurely or with certain medical conditions.

Common effects may include mild redness or swelling at the injection site, but serious side effects are rare.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.